Inventor · disambiguated record
Kenneth J. Widder
Also filed as: WIDDER KENNETH · WIDDER KENNETH J
40 granted patents·34 pending applications·2,560 citations·filing 1977–2025
98Inventor score
Top patents by PatentIndex Score
74 records- 0199US4345588AMethod of delivering a therapeutic agent to a target capillary bedUNIV NORTHWESTERN·Filed 1980·Granted Aug 24, 1982·286 cites·12 claims
- 0298US11596625B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 7, 2023·9 cites·20 claims
- 0398US10953002B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 23, 2021·11 cites·15 claims
- 0498US10940145B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Mar 9, 2021·19 cites·23 claims
- 0598US10888557B2Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Jan 12, 2021·20 cites·23 claims
- 0698US10813923B1Ophthalmic compositionSYDNEXIS INC·Filed 2020·Granted Oct 27, 2020·11 cites·15 claims
- 0798US9421199B2Ophthalmic compositionSYDNEXIS INC·Filed 2015·Granted Aug 23, 2016·45 cites·27 claims
- 0898US4230685AMethod of magnetic separation of cells and the like, and microspheres for use thereinUNIV NORTHWESTERN·Filed 1979·Granted Oct 28, 1980·278 cites·10 claims
- 0997US11052095B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2020·Granted Jul 6, 2021·7 cites·14 claims
- 1097US10864208B2Ophthalmic compositionSYDNEXIS INC·Filed 2018·Granted Dec 15, 2020·7 cites·32 claims
- 1197US10842787B2Ophthalmic compositionSYDNEXIS INC·Filed 2016·Granted Nov 24, 2020·15 cites·19 claims
- 1297US10201534B2Ophthalmic compositionSYDNEXIS INC·Filed 2018·Granted Feb 12, 2019·19 cites·30 claims
- 1397US10076515B2Ophthalmic CompositionSYDNEXIS INC·Filed 2017·Granted Sep 18, 2018·16 cites·20 claims
- 1497US9770447B2Ophthalmic compositionSYDNEXIS INC·Filed 2016·Granted Sep 26, 2017·21 cites·19 claims
- 1596US11896588B2Ophthalmic compositionSYDNEXIS INC·Filed 2022·Granted Feb 13, 2024·2 cites·20 claims
- 1696US5315997AMethod of magnetic resonance imaging using diamagnetic contrastMOLECULAR BIOSYSTEMS INC·Filed 1992·Granted May 31, 1994·159 cites·6 claims
- 1796US4357259AMethod of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheresUNIV NORTHWESTERN·Filed 1977·Granted Nov 2, 1982·131 cites·4 claims
- 1895US11883390B2Ophthalmic compositionSYDNEXIS INC·Filed 2022·Granted Jan 30, 2024·1 cites·20 claims
- 1995US11382909B2Ophthalmic compositionSYDNEXIS INC·Filed 2019·Granted Jul 12, 2022·4 cites·25 claims
- 2095US5536489AEmulsions as contrast agents and method of useMOLECULAR BIOSYSTEMS INC·Filed 1995·Granted Jul 16, 1996·206 cites·11 claims
- 2195US4844882AConcentrated stabilized microbubble-type ultrasonic imaging agentMOLECULAR BIOSYSTEMS INC·Filed 1987·Granted Jul 4, 1989·356 cites·8 claims
- 2295US4675173AMethod of magnetic resonance imaging of the liver and spleenMOLECULAR BIOSYSTEMS INC·Filed 1985·Granted Jun 23, 1987·116 cites·14 claims
- 2395US4247406AIntravascularly-administrable, magnetically-localizable biodegradable carrierWIDDER KENNETH J·Filed 1979·Granted Jan 27, 1981·208 cites·12 claims
- 2494US11890277B2Ophthalmic compositionSYDNEXIS INC·Filed 2022·Granted Feb 6, 2024·1 cites·20 claims
- 2592US11052094B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2016·Granted Jul 6, 2021·8 cites·28 claims
- 2691US5716597AEmulsions as contrast agents and method of useMOLECULAR BIOSYSTEMS INC·Filed 1993·Granted Feb 10, 1998·102 cites·13 claims
- 2791US2024398705A1Ophthalmic compositionSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 2889US12070466B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2021·Granted Aug 27, 2024·1 cites·18 claims
- 2988US2024165098A1Ophthalmic compositionSYDNEXIS INC·Filed 2023·Application pending·0 cites
- 3088US2025275983A1D2o stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 3187US5107842AMethod of ultrasound imaging of the gastrointestinal tractMOLECULAR BIOSYSTEMS INC·Filed 1991·Granted Apr 28, 1992·115 cites·15 claims
- 3285US2022409604A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3385US2022409603A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3485US2022409605A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3585US2025255810A1Ophthalmic compositionSYDNEXIS INC·Filed 2025·Application pending·0 cites
- 3683US2022265632A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3783US2025186251A1Ophthalmic composition and delivery device thereofSYDNEXIS INC·Filed 2024·Application pending·0 cites
- 3883US2022265631A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 3982US4849210AMagnetic resonance imaging of liver and spleen with superparamagnetic contrast agentsMOLECULAR BIOSYSTEMS INC·Filed 1987·Granted Jul 18, 1989·65 cites·7 claims
- 4082US2022378775A1Ophthalmic compositionSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 4180US2023381016A1Ophthalmic composition and delivery device thereofSYDNEXIS INC·Filed 2023·Application pending·0 cites
- 4277US12168017B2D2O stabilized pharmaceutical formulationsSYDNEXIS INC·Filed 2021·Granted Dec 17, 2024·0 cites·20 claims
- 4375US8410168B2Methods and compositions for treating ophthalmic conditions with retinyl derivativesWIDDER KENNETH·Filed 2010·Granted Apr 2, 2013·3 cites·12 claims
- 4471US7432307B2Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formationSIRION THERAPEUTICS INC·Filed 2005·Granted Oct 7, 2008·2 cites·3 claims
- 4571US5732707AMethod of ultrasonically quantitating myocardial perfusion using as intravenously injected tracerMOLECULAR BIOSYSTEMS INC·Filed 1996·Granted Mar 31, 1998·211 cites·10 claims
- 4670US8314152B2Methods and compositions for treating ophthalmic conditions with retinyl derivativesWIDDER KENNETH·Filed 2005·Granted Nov 20, 2012·1 cites·7 claims
- 4765US2020345542A1Ophthalmic composition and delivery device thereofSYDNEXIS INC·Filed 2018·Application pending·0 cites
- 4864US5385147AMethod of ultrasonic imaging of the gastrointestinal tract and upper abdominal organs using an orally administered negative contrast mediumMOLECULAR BIOSYSTEMS INC·Filed 1993·Granted Jan 31, 1995·34 cites·19 claims
- 4960US2024139166A1Ophthalmic compositions for presbyopiaSYDNEXIS INC·Filed 2022·Application pending·0 cites
- 5056US2006135460A1Methods, assays and compositions for treating retinol-related diseasesSYTERA INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →